Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacy Benefit Managers, Brand-Name Drug Prices, and Patient Cost Sharing.

× No keyword cloud information.

7 in total

1. Decomposition Analysis of Spending and Price Trends for Biologic Antirheumatic Drugs in Medicare and Medicaid.

Authors: Natalie McCormick; Zachary S Wallace; Chana A Sacks; John Hsu; Hyon K Choi
Journal: Arthritis Rheumatol Date: 2020-01-06 Impact factor: 10.995

2. Trends of Prescription Drug Manufacturer Rebates in Commercial Health Insurance Plans, 2015-2019.

Authors: Elizabeth Plummer; Mariana P Socal; Jeromie M Ballreich; Gerard F Anderson; Ge Bai
Journal: JAMA Health Forum Date: 2022-05-06

3. Value-based Pricing for Rifaximin Increases Access of Patients With Irritable Bowel Syndrome With Diarrhea to Therapy.

Authors: Eric D Shah; Sameer D Saini; William D Chey
Journal: Clin Gastroenterol Hepatol Date: 2019-03-01 Impact factor: 11.382

4. Value-based drug pricing in the Biden era: Opportunities and prospects.

Authors: Peter J Neumann; Daniel A Ollendorf; Joshua T Cohen
Journal: Health Serv Res Date: 2021-06-03 Impact factor: 3.734

Review 5. Bending Versus Transforming the Drug Cost Curve: A Matter of Political Will.

Authors: Ajay Major; Blase N Polite
Journal: Cancer J Date: 2020 Jul/Aug Impact factor: 2.074

6. Drug costs in context: assessing drug costs in cost-of-illness analyses.

Authors: T Joseph Mattingly; Shannon Weathers
Journal: Drugs Context Date: 2022-07-21

7. Measurement of the Equality of the Drug Welfare Induction Level of Chinese Patients With Chronic Diseases in Gansu, Sichuan, Hebei, and Zhejiang Based on the Bivariate Theil-T Index Method.

Authors: Shaoliang Tang; Ruxia Zhang; Yinghang Si; Yan Cheng; Ying Gong
Journal: Front Public Health Date: 2020-10-28

7 in total